Grants and Contracts Details
Description
No major changes have occurred since the prior application.
B. PROGRESS
I have completed TOX 600 "Research Ethics", a course which dealt with ethical issues in the
conduct of both animal and human research, and have completed other laboratory training (i.e., hazardous
materials, etc.). I have also continued to attend the Neuropharmacology Journal Club through the UK
College of Pharmacy and the monthly Local NIDA ("Neuroscientists Interested in Drug Abuse") meetings. I
am also scheduled to present a talk at the Local NIDA meeting in February 2009.
Regarding research activity, I have been involved in several research projects since the submission
of the last application. In addition to ongoing work dedicated to characterizing the behavioral effects of
novel nAChR antagonists as potential smoking cessation medications, I have involved with supervising an
undergraduate honor's thesis project comparing the effects of oral vs. intraperitonéal methylphenidate (10
mg/kg) in the locomotor activity and conditioned place preference procedures. While preliminary, our
findings to date suggest that although the locomotor stimulant effect of oral methylphenidate is minor
relative to intraperitoneal methylphenidate, rats express comparable methylphenidate-conditioned place
preference for 10 mg/kg of methylphenidate given via either route. The next round of experiments will
assess the parameteric (i.e., dose and PK parameters) aspects of the initial findings in further detail. I have
also recently initiated another experiment comparing the effects of methylphenidate and other stimulant
drugs on performance of an operant delay-discounting task in Sprague-Dawley (S-D), Spontaneously
Hypertensive (SHR) and Wistar-Kyoto(WKY) rat strains; similar to the experiments outlined in the present
application, those data should provide information regarding the viability of the SHR animal model of
attention-deficit/hyperactivity disorder (ADHD). Regarding the NRSA project specifically, I have completed
periadolescent treatment of SHR and S-D rats with oral methylphenidate. Results obtained thus far suggest
that periadolescent SHR are hypersensitive to methylphenidate compared to S-D rats. The next phase of
the project will determine whether these findings lead to alterations in the response to cocaine.
| Status | Finished |
|---|---|
| Effective start/end date | 3/24/08 → 3/23/10 |
Funding
- National Institute on Drug Abuse: $29,508.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.